SIMILASAN Affections cutanées crème tb 50 g

7680516780295 CH-51678 20.01.1.
SIMILASAN Affections cutanées crème tb 50 g
SIMILASAN Affections cutanées crème tb 50 g
SIMILASAN Affections cutanées crème tb 50 g
1 / 3
google

Details

Product number
5167801
CPT
-
Packaging group
50
Unit
g
Composition
mercurius solubilis hahnemanni (HAB) D12 25 mg, natrium chloratum (HAB) D12 (Ph.Eur.Hom. 3.1.1) 25 mg, rhus toxicodendron (HAB) D10 25 mg, selenium metallicum (HAB) D15 25 mg, aqua ad iniectabile, alcohol cetylicus 100 mg, arachidis oleum hydrogenatum 200 mg, polysorbatum 60 50 mg, propylenglycolum 200 mg, natrii chloroargentas, ad unguentum pro 1 g.

Articles (1)

Similasan Hautausschläge, Creme
Creme
50
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
05/02/2024
Patient information leaflet
Français
05/02/2024
Patient information leaflet
Italien
05/02/2024

Detailed composition

Substance Quantity Type Category
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
25.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
100.0 MG Substance HBESI
(N/A)
200.0 MG Substance HBESI
(N/A)
50.0 MG Substance HBESI
(N/A)
200.0 MG Substance HBESI
(N/A)
- Substance Konservierungsstoff (Conservateur)

Authorization holder

Similasan AG

8916 Jonen

Authorization information

Swissmedic authorization number
51678
Drug name
Similasan Hautausschläge, Creme
Galenic form
CREM
Authorization status
Z
Dispensation category
D
First authorization
26/05/1992
Authorization expiration date
31/12/9999
IT number
20.01.1.
Domain
Human medicine
Field of application
Gemäss homöopathischem Arzneimittelbild bei Hautausschlägen

Packaging details

Description (FR)
SIMILASAN Affections cutanées crème tb 50 g
Description (DE)
SIMILASAN Hautausschläge Creme Tb 50 g
Market launch
26/05/1992
Narcotic (BTM)
No

Other packaging sizes